Published in Evid Based Complement Alternat Med on December 01, 2007
Potential benefits on impairment of endothelial function after a high-fat meal of 4 weeks of flavonoid supplementation. Evid Based Complement Alternat Med (2011) 0.99
Fermented wheat germ extract (avemar) in the treatment of cardiac remodeling and metabolic symptoms in rats. Evid Based Complement Alternat Med (2011) 0.86
Effects of red grape juice consumption on high density lipoprotein-cholesterol, apolipoprotein AI, apolipoprotein B and homocysteine in healthy human volunteers. Open Biochem J (2010) 0.82
Effects and Mechanisms of Fruit and Vegetable Juices on Cardiovascular Diseases. Int J Mol Sci (2017) 0.75
Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol (1990) 28.97
Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA (2004) 9.99
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int (2002) 9.29
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 7.41
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet (1993) 6.53
Intensive lifestyle changes for reversal of coronary heart disease. JAMA (1998) 6.53
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet (1996) 6.48
The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37
Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet (2000) 6.19
Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 5.09
Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology (1998) 4.48
Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet (1997) 4.19
Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr (1999) 3.89
Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med (2004) 3.64
Evidence-based guidelines for cardiovascular disease prevention in women. Circulation (2004) 3.39
Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol (2003) 3.37
Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation (2000) 3.18
A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation (2004) 3.03
Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med (1998) 2.85
Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation (2003) 2.63
Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60
Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ (1998) 2.02
Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation (2002) 1.99
The 6-a-day study: effects of fruit and vegetables on markers of oxidative stress and antioxidative defense in healthy nonsmokers. Am J Clin Nutr (2004) 1.82
Effect of supplemental phytonutrients on impairment of the flow-mediated brachial artery vasoactivity after a single high-fat meal. J Am Coll Cardiol (2003) 1.81
Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr (2004) 1.70
The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults: a randomized trial. Ann Intern Med (2005) 1.69
The state of the art of traditional arab herbal medicine in the eastern region of the mediterranean: a review. Evid Based Complement Alternat Med (2006) 1.60
Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol (2003) 1.40
Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus. Hypertension (2005) 1.37
By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? Eur J Clin Nutr (1998) 1.34
Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 system: Reliability, repeatability, and establishment of normal values for healthy European population--the seven European sites study (SESS). Am J Hypertens (2005) 1.33
Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J Nutr (2004) 1.24
Mortality in British vegetarians: review and preliminary results from EPIC-Oxford. Am J Clin Nutr (2003) 1.12
Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology (2001) 1.08
Coronary age as a risk factor in the modified Framingham risk score. BMC Med Imaging (2004) 1.04
Estimated phytochemical content of the dietary approaches to stop hypertension (DASH) diet is higher than in the Control Study Diet. J Am Diet Assoc (2004) 0.99
Variability of repeated coronary artery calcium measurements by electron beam tomography. Am J Cardiol (2001) 0.87
Case-control study of nonfatal myocardial infarction in relation to selected foods in Japanese men and women. Jpn Circ J (2001) 0.82
Coronary calcium screening and coronary risk stratification. Curr Atheroscler Rep (2004) 0.77
Cholesterol management in the era of managed care. Am J Cardiol (2000) 0.77
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int (2007) 6.34
Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology (1998) 4.48
Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int (2006) 3.39
Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation (2000) 3.18
Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med (1998) 2.85
Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest (1998) 1.74
Evaluation of chest pain in patients with low to intermediate pretest probability of coronary artery disease by electron beam computed tomography. Am J Cardiol (2000) 1.50
Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus. Lupus (2011) 1.41
Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J (2001) 1.27
Long-term comparison of a calcium-free phosphate binder and calcium carbonate--phosphorus metabolism and cardiovascular calcification. Clin Nephrol (2004) 1.10
Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus (2009) 1.10
Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. Lupus (2006) 1.09
Coronary artery disease progression assessed by electron-beam computed tomography. Am J Cardiol (2001) 0.96
Markers of vascular disease do not differ in black and white hemodialysis patients despite a different risk profile. Atherosclerosis (2007) 0.89
Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus. Lupus (2011) 0.84
Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease. J Am Coll Cardiol (1998) 0.79
Electron beam tomography as a non invasive method to monitor effectiveness of antiatherosclerotic therapy. Curr Drug Targets Cardiovasc Haematol Disord (2004) 0.79
Sensitivity of two electron beam tomography protocols for the detection and quantification of coronary artery calcium. AJR Am J Roentgenol (2000) 0.78
Influence of prior ACE inhibitor therapy on morbidity and mortality following acute myocardial infarction. Ann Pharmacother (1998) 0.78
Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus. Lupus (2012) 0.77
The HCA National Disease Management Program for coronary disease detection and treatment in women. Am J Manag Care (2001) 0.76
Novel agents to manage dyslipidemias and impact atherosclerosis. Cardiovasc Hematol Disord Drug Targets (2006) 0.76
Electron-beam computed tomography for evaluating coronary artery disease. Ann Intern Med (1998) 0.75
Therapeutic theophylline levels and adverse cardiac events. Ann Intern Med (1994) 0.75
Detection of coronary vasospasm by posthyperventilation technetium-99m sestamibi single-photon emission computed tomography imaging in patients with coronary artery disease. Am J Cardiol (1998) 0.75
Evaluation of the influence of open and closed-ampoule technologies on particulate matter in small-volume parenterals. J Parenter Sci Technol (1994) 0.75
Evaluation of factors influencing ampoule secondary particulate contamination. A strategy for its reduction in small volume parenterals. Boll Chim Farm (1991) 0.75
Electron-beam computed tomography: a Bayesian approach to risk assessment. Am J Cardiol (2001) 0.75
Not for money, but for life. Ann Intern Med (1995) 0.75
Symptoms of patients with silent ischemia as detected by thallium stress testing. Chest (1994) 0.75